TBA: Transbrachial Access for Interventions in Patients With Peripheral Arterial Occlusive Disease

Sponsor
Wilhelminenspital Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT05892367
Collaborator
(none)
95
1
2
26.8
3.5

Study Details

Study Description

Brief Summary

The aim of the present study is an evaluation, whether an immobilization of the upper extremity by means of a positioning splint can help to reduce the incidence of local complications after transbrachial puncture for peripheral arterial interventions, or not.

Condition or Disease Intervention/Treatment Phase
  • Other: Transbrachial Access for Interventions
N/A

Detailed Description

Increasing numbers of peripheral arterial interventions are performed via transbrachial access leading to a higher number of local complications at the puncture site. Patients are demonstrating complications, such as hematoma, false aneurysm, secondary hemorrhage and arterial stenosis or occlusion.

Due to not standardized post-interventional procedure regarding to immobilization a higher risk for local puncture site complication can occur. Usually, a compression bandage its applied to the brachial puncture site. Within this randomized study, patients randomized to the study group will receive an additional splint for 24 hours to ensure an immobilization of the affected arm.

Following the removal of the compression dressing, and the splint in the study group, a duplex ultrasound its performed in order to detect local alterations and pathologies of the brachial artery.

This examination is repeated for each patient in the course of an outpatient control six weeks post-interventionally. Pathologies are documented and treated if necessary.

Study Design

Study Type:
Interventional
Actual Enrollment :
95 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Control group: compression bandage Study group: compression bandage and positioning splintControl group: compression bandage Study group: compression bandage and positioning splint
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Transbrachial Access for Interventions in Patients With Peripheral Arterial Occlusive Disease: Evaluation of Local Complications With or Without Post-interventional Immobilization of the Upper Extremity
Actual Study Start Date :
Jul 10, 2018
Actual Primary Completion Date :
Aug 21, 2020
Actual Study Completion Date :
Oct 2, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Control group

Application of a compression bandage following transbrachial puncture for 24 hours

Other: Transbrachial Access for Interventions
Adding a positioning splint in addition to compression bandage after intervention in order to guarantee immobilization of puncture site

Active Comparator: Study group

Application of a compression bandage and a positioning splint following transbrachial puncture for 24 hours

Other: Transbrachial Access for Interventions
Adding a positioning splint in addition to compression bandage after intervention in order to guarantee immobilization of puncture site

Outcome Measures

Primary Outcome Measures

  1. Occurrence of local complications at the puncture site [6 weeks]

    Local complications as hematoma, bleeding, pseudoaneurysm, arterial dissection, arterial stenosis, arterial occlusion, AV fistula detected by ultrasound 24 hours after intervention and at time of follow-up six weeks after treatment

Secondary Outcome Measures

  1. Post-interventional pain at puncture site [24 hours]

    Evaluation of local pain according to V.A.S. score by asking patients after intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female and male patients suffering from peripheral arterial occlusive disease with indicated interventions via an transbrachial access (puncture of the left or right brachial artery)

  • age > 18 years

  • approval to participate

Exclusion Criteria:
  • unability or refusal to participate

  • dialysis patients/AV-fistula interventions

  • usage of closure devices

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Vascular and Endovascular Surgery Vienna Austria 1160

Sponsors and Collaborators

  • Wilhelminenspital Vienna

Investigators

  • Principal Investigator: Afshin Assadian, Prim. PD Dr., Vascular and Endovascular Surgery, Klinik Ottakring

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Edda Skrinjar, M.D., M.D., Wilhelminenspital Vienna
ClinicalTrials.gov Identifier:
NCT05892367
Other Study ID Numbers:
  • TBA 1.2
First Posted:
Jun 7, 2023
Last Update Posted:
Jun 7, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Edda Skrinjar, M.D., M.D., Wilhelminenspital Vienna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2023